ScienceNeurosciencePeer-reviewed journal article
Complement factor C1q mediates chronic neuron loss and inflammation post-brain injury
Stephanie S. HoldeniD, Fiorella Carla GrandiiD, Oumaima AboubakriD, Bryan T. HigashikuboiD, Frances S. ChoiD, Andrew H. ChangiD, Alejandro Osorio-ForeroiD, Allison R. MorningstariD, Vidhu Mathur, Logan J. KuhniD, Poojan Suri, Sethu SankaranarayananiD, Yaisa S. Andrews-Zwilling, Andrea J. TenneriD, Anita LüthiiD, Eleonora AronicaiD, M. Ryan CorcesiD, Ted A. YednockiD, Jeanne T. PaziD
Abstract
While traumatic brain injury (TBI) acutely disrupts the cortex, most TBI-related disabilities reflect secondary injuries that accrue over time. The thalamus is a likely site of secondary damage because of its reciprocal connections with the cortex. Using a mouse model of cortical injury that does not directly damage subcortical structures, we found a chronic increase in C1q expression specifically in the corticothalamic circuit. Increased C1q expression co-localized with neuron loss and chronic inflammation, and correlated with altered cortical rhythms. Blocking C1q counteracted most of these outcomes, suggesting that C1q is a disease modifier in TBI. Since the corticothalamic circuit is important for sensory processing, attention, cognition, and sleep, all of which can be impaired by TBI, this circuit could be a new target for treating TBI-related disabilities.
- Citations
- 133
- FWCI
- 9.32
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- C1q/CTRP1 exerts neuroprotective effects in TBI rats by regulating inflammation and autophagy
- C-terminal binding proteins 1 and 2 in traumatic brain injury-induced inflammation and their inhibition as an approach for anti-inflammatory treatment
Hong Li, Caiguo Zhang, … Mingxia Huang·International Journal of Biological SciencesPeer-reviewed·Jan 1, 2020
- Increased CD3 Immunoreactive Cells Persist Chronically in the Brain Parenchyma in Association with Focal Cortical Contusion following Experimental TBI
Kristen D Esannason Munroe, Alexandra V. Ulyanova, … John A. Wolf·bioRxiv·Feb 15, 2026
- Microglial depletion with CSF1R inhibitor during chronic phase of experimental traumatic brain injury reduces neurodegeneration and neurological deficits
Rebecca J. Henry, Rodney M. Ritzel, … David J. Loane·Journal of NeurosciencePeer-reviewed·Feb 24, 2020
- Cerebral microthrombi promote focal Cav-1-dependent blood-brain barrier impairment, triggering neuroinflammation and neuronal damage after traumatic brain injury
Antonia Clarissa Wehn, Martina Schifferer, … Igor Khalin·bioRxiv·Oct 14, 2026
- A neuroprotective tetrapeptide for treatment of acute traumatic brain injury
Aman P. Mann, Sazid Hussain, … Erkki Ruoslahti·EMBO Molecular MedicinePeer-reviewed·Oct 1, 2025